IL87321A - 1,4-dihydropyridines, their preparationand pharmaceutical compositionscontaining them - Google Patents

1,4-dihydropyridines, their preparationand pharmaceutical compositionscontaining them

Info

Publication number
IL87321A
IL87321A IL87321A IL8732188A IL87321A IL 87321 A IL87321 A IL 87321A IL 87321 A IL87321 A IL 87321A IL 8732188 A IL8732188 A IL 8732188A IL 87321 A IL87321 A IL 87321A
Authority
IL
Israel
Prior art keywords
methyl
preparationand
dihydropyridines
substd
opt
Prior art date
Application number
IL87321A
Other languages
English (en)
Other versions
IL87321A0 (en
Original Assignee
Delagrange Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delagrange Lab filed Critical Delagrange Lab
Publication of IL87321A0 publication Critical patent/IL87321A0/xx
Publication of IL87321A publication Critical patent/IL87321A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
IL87321A 1987-08-03 1988-08-02 1,4-dihydropyridines, their preparationand pharmaceutical compositionscontaining them IL87321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401799A EP0302980B1 (fr) 1987-08-03 1987-08-03 1,4-Dihydropyridines, leur procédé de préparation et leur application comme médicaments

Publications (2)

Publication Number Publication Date
IL87321A0 IL87321A0 (en) 1989-01-31
IL87321A true IL87321A (en) 1993-04-04

Family

ID=8198243

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87321A IL87321A (en) 1987-08-03 1988-08-02 1,4-dihydropyridines, their preparationand pharmaceutical compositionscontaining them

Country Status (34)

Country Link
US (1) US4952592A (xx)
EP (1) EP0302980B1 (xx)
JP (1) JPH0733383B2 (xx)
KR (1) KR960001724B1 (xx)
CN (1) CN1038587C (xx)
AT (1) ATE61588T1 (xx)
BE (1) BE1001055A4 (xx)
CA (2) CA1306261C (xx)
CH (1) CH675999A5 (xx)
CZ (1) CZ282077B6 (xx)
DD (1) DD282008A5 (xx)
DE (2) DE3768658D1 (xx)
DK (1) DK430288A (xx)
ES (1) ES2007543A6 (xx)
FI (1) FI91406C (xx)
GB (1) GB2208861B (xx)
GR (2) GR880100507A (xx)
HU (1) HU204523B (xx)
IE (1) IE60358B1 (xx)
IL (1) IL87321A (xx)
IN (1) IN167550B (xx)
IS (1) IS1549B (xx)
IT (1) IT1235013B (xx)
LU (1) LU87297A1 (xx)
MA (1) MA21344A1 (xx)
NO (1) NO170934C (xx)
NZ (1) NZ225661A (xx)
PH (1) PH25645A (xx)
PT (1) PT88173B (xx)
RU (1) RU2036922C1 (xx)
SK (1) SK278775B6 (xx)
TN (1) TNSN88081A1 (xx)
YU (1) YU46547B (xx)
ZA (1) ZA885684B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242933A (en) * 1990-07-10 1993-09-07 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5942516A (en) * 1995-08-02 1999-08-24 Elliott; John Duncan Endothelin receptor antagonists
ES2287110T3 (es) * 2000-04-11 2007-12-16 Sankyo Company, Limited Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina.
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
CN101090714A (zh) * 2004-07-26 2007-12-19 康泽里克斯公司 通过吸入伊洛前列素和微粒制剂治疗肺动脉高血压症
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7893050B2 (en) * 2005-10-26 2011-02-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3441648A (en) * 1967-02-07 1969-04-29 Smithkline Corp Compositions and methods for lowering blood pressure with 1,4-dihydropyridines
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS5978186A (ja) * 1982-10-27 1984-05-04 Yoshitomi Pharmaceut Ind Ltd １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
ES531033A0 (es) * 1984-03-27 1985-09-01 Inst Investigacion Desarrollo Un procedimiento para la preparacion de nuevas 1,4-dihidropirinas-4-(polioxialquilfenil)-sustituidas
JPH068294B2 (ja) * 1985-02-26 1994-02-02 富山化学工業株式会社 新規な１，４−ジヒドロピリジン誘導体およびその塩
EP0174131A3 (en) * 1984-09-01 1989-06-07 FISONS plc Dihydropyridines, processes and intermediates for their production, and pharmaceutical formulations containing them
JPH01207267A (ja) * 1987-03-05 1989-08-21 Yamanouchi Pharmaceut Co Ltd ピリジン誘導体及び該化合物を含有する肝疾患治療剤

Also Published As

Publication number Publication date
LU87297A1 (fr) 1989-02-02
NO170934B (no) 1992-09-21
KR960001724B1 (ko) 1996-02-03
SK541388A3 (en) 1998-02-04
NZ225661A (en) 1990-08-28
GB8818356D0 (en) 1988-09-07
RU2036922C1 (ru) 1995-06-09
IT8848259A0 (it) 1988-08-02
GR3001984T3 (en) 1992-11-23
MA21344A1 (fr) 1989-04-01
DK430288D0 (da) 1988-08-02
CA1306262C (fr) 1992-08-11
AU2033088A (en) 1989-02-09
NO883406D0 (no) 1988-08-01
ZA885684B (en) 1989-04-26
IE882364L (en) 1989-02-03
CZ541388A3 (en) 1997-01-15
IS3378A7 (is) 1989-02-04
CN1031531A (zh) 1989-03-08
IS1549B (is) 1994-06-08
DD282008A5 (de) 1990-08-29
FI883603A0 (fi) 1988-08-01
NO883406L (no) 1989-02-06
FI91406C (fi) 1994-06-27
GB2208861A (en) 1989-04-19
PT88173A (pt) 1989-06-30
CN1038587C (zh) 1998-06-03
FI883603A (fi) 1989-02-04
IN167550B (xx) 1990-11-10
AU606441B2 (en) 1991-02-07
GR880100507A (el) 1989-05-25
DE3768658D1 (de) 1991-04-18
SK278775B6 (sk) 1998-02-04
DE3825962A1 (de) 1989-02-16
JPH0733383B2 (ja) 1995-04-12
CZ282077B6 (cs) 1997-05-14
GB2208861B (en) 1991-07-17
IE60358B1 (en) 1994-06-29
ATE61588T1 (de) 1991-03-15
IL87321A0 (en) 1989-01-31
TNSN88081A1 (fr) 1990-07-10
KR890003743A (ko) 1989-04-17
CH675999A5 (en) 1990-11-30
NO170934C (no) 1992-12-30
HUT54142A (en) 1991-01-28
PH25645A (en) 1991-08-21
YU147088A (en) 1990-04-30
US4952592A (en) 1990-08-28
DK430288A (da) 1989-02-03
JPH01294675A (ja) 1989-11-28
CA1306261C (fr) 1992-08-11
BE1001055A4 (fr) 1989-06-20
EP0302980A1 (fr) 1989-02-15
IT1235013B (it) 1992-06-16
HU204523B (en) 1992-01-28
PT88173B (pt) 1995-03-01
EP0302980B1 (fr) 1991-03-13
ES2007543A6 (es) 1989-06-16
YU46547B (sh) 1993-11-16
FI91406B (fi) 1994-03-15

Similar Documents

Publication Publication Date Title
IL87321A (en) 1,4-dihydropyridines, their preparationand pharmaceutical compositionscontaining them
FI900307A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivista 3-/3-okso-(2,3)-dihydropyridatsin-6-yyli/-2-fenyyli-pyratsolo/1,5-a/pyridiinijohdannaisia
TW360656B (en) Purin-6-one derivatives having cGMP-metabolizing PDEs inhibiting activity, the preparation processes and the pharmaceutical preparation thereof
AU589427B2 (en) Pyridonecarboxylic acid derivatives and process for their preparation
NL940010I2 (nl) Nieuwe 2beta-morfolino-androstaanderivaten en werkwijze voor de bereiding daarvan.
FI91529B (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyrido/1,2,3-de//1,4/bentsoksatsiinijohdannaisten valmistamiseksi
NO173184C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridin-2,4- og 2,5-dikarboksylsyrederivater
ATE47398T1 (de) 10-beta-alkynyl-estrenderivate und verfahren zu ihrer herstellung.
IE44154L (en) 1,3,8-triazaspiro(4,5) decan-4-one derivatives
IE813100L (en) Naphthyridine derivatives
SE8605255L (sv) 4h-benso(4,5)cyklohepta(1,2-b)tiofen-derivat
FI934303A (fi) Acylsulfonamido- och sulfonamidopyridin-2-karboxylsyraestrar och deras pyridin-N-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
LV5737A4 (lv) Tetrahidro-1H-piridoÚ4,3-b¾indol-1-ona atvasinajumi
FI943730A0 (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi

Legal Events

Date Code Title Description
KB Patent renewed
HE Change of address of proprietor(s)
MM9K Patent not in force due to non-payment of renewal fees